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1142-179 Body Fat Distribution Influences Cardiac Output in 
Normotensive and Hypertensive Overweight 
Individuals: The HyperGEN Study
Giovanni de Simone, Richard B. Devereux, Marcello Chinali, Vittorio Palmieri, Albert 
Oberman, Dalane W. Kitzman, Paul N. Hopkins, D. C. Rao, Donna K. Arnett, Weill 
Medical College, New York, NY, Federico II University, Napoli, Italy
Background: We have shown that in obesity increased cardiac output is related to fat-
free mass but also to adipose mass. Whether these relations are present in milder over-
weight and similar with central (CFD) or peripheral fat distribution (PFD) has never been
explored in population studies. Method: 522 overweight, non-obese participants (NIH
1998) in the HyperGEN study, without diabetes or known cardiovascular disease, and
with normal LV function were studied (262 with CFD, by waist girth>88/102 cm in women/
men). Fat-free and adipose mass were measured by bioelectric impedance and body
composition was estimated as the ratio of adipose to fat-free mass (A/FFMr). Stroke vol-
ume (SV) and cardiac output (CO) were measured by echocardiography. Results:
Hypertension was present in 73% of PFD and 78% of CFD. Table shows that overweight
with CFD was associated with greater adiposity, similar in normotensive and hyperten-
sive participants. At comparable fat-free mass, CO was higher in overweight with CFD
than in PFD, whereas peripheral resistance was similar. CO was related to adipose mass
(beta=0.13, p<0.01), independently of fat-free mass (beta=0.30, both p<0.0001) and Afri-
can-American ethnicity (beta=0.10, p<0.03); no independent relations were found with
age, sex or hypertension. Conclusions: in overweight, non obese subjects, central fat
distribution is associated with more severe degree of abnormalities in body composition
and influences magnitude of cardiac output independently of fat-free mass.
1142-180 Peroxisome Proliferator-Activated Receptor-Alpha 
Intron 7 Polymorphism Exhibits Racial Dimorphism and 
Is Associated With Increased Left Ventricular Mass
Lisa de las Fuentes, Sheng-Jing Dong, Alan D. Waggoner, Sharon Cresci, Sharon 
Marsh, Howard L. McLeod, Daniel P. Kelly, Victor G. Davila-Roman, Washington 
University, Saint Louis, MO
Background: Peroxisome proliferator-activated receptor-alpha (PPARα) is a key tran-
scription regulator of myocardial fatty acid metabolism. Recently an intron 7 G>C poly-
morphism in the PPARα gene was associated with pathologic left ventricular (LV)
hypertrophy in Caucasian men, but not in women. The frequency of the polymorphism
and its influence on measures of myocardial LV mass (LVM) has not been well evaluated
in a racially mixed population.
Methods and Results: The PPARα intron 7 G>C polymorphism was genotyped in 107
subjects to investigate a relationship with LVM. There was no significant difference in sys-
tolic BP, LV ejection fraction (LVEF) or history of HTN between the 4 groups, or within the
groups between genotypes. The allelic frequencies were racially dimorphic [C allele fre-
quency =0.22 in Non-African Americans (NAA) and 0.52 in African Americans (AA)].
Among NAA women, the intron 7 CC genotype was significantly associated with
increased LVM (LVM/Ht2.7, p<0.001 vs. GG and GC); a similar association was found
among NAA men (p=0.048 GG vs. CC). No association of intron 7 genotypes and LVM
were found among AA women or men, albiet this subgroup had a smaller sample size.
Conclusions: 1) The PPARα intron 7 G>C polymorphism is racially dimorphic and 2)
this study confirms the influence of the PPARα intron 7 CC genotype on LVH in NAA
men, and extends this to NAA women. Given the racial dimorphism in allelic frequencies
further investigation is warranted to evaluate whether the C allele is associated with LVM
in AA.
1142-181 Does Indexation to Fat-Free Mass Eliminate or Reverse 
Gender Differences in Left Ventricular Mass?
Michael L. Chuang, Carol J. Salton, Kraig V. Kissinger, Christopher J. O'Donnell, Daniel 
Levy, Warren J. Manning, Beth Israel Deaconess Medical Center, Boston, MA, NHLBI's 
Framingham Heart Study, Framingham, MA
Mean left ventricular mass (LVM) is greater in men than women, regardless of indexation
to height (Ht) or body surface area (BSA). Indexation to fat-free body mass (FFM) may
better reflect metabolic demand, potentially allowing improved identification of inappropri-
ately elevated LVM, but the gender-differential effect of indexation to FFM on LVM by car-
diovascular magnetic resonance (CMR) is unknown.
Methods: Clinically healthy adults (144 women and 135 men, aged 59±9 years) from the
Framingham Offspring cohort underwent volumetric FFE-EPI CMR (1.5T, Philips) to
determine LVM. FFM was determined using two gender-specific methods: Kvist formula
FFM=Wt-(0.923*(1.36*Wt/Ht-42.0)), men, FFM=Wt-(0.923*(1.61*Wt/Ht-38.3)), women,
Wt=weight. Kuch FFM= 5.1*Ht^1.14*Wt^0.41, men; FFM=5.34*Ht^1.47*Wt^0.33,
women. LVM was indexed to Ht, Wt, BSA, Ht^2.7 and Kvist and Kuch FFM. Gender differ-
ences were assessed by Student’s t test.
Results: Men had significantly greater LVM (Table) before and after indexation to Ht,
Ht^2.7, BSA and Wt. Indexation to Kuch-FFM eliminated gender differences in LVM,
while Kvist-FFM gave significantly greater adjusted LVM in women.
Conclusion: Men have greater LVM than women and this gender difference persists after
traditional indexation methods. However, indexation to FFM eliminates LVM gender differ-
ences (Kuch) or gives greater indexed LVM in women (Kvist). Further work is needed to
determine the prognostic value of volumetric LVM indexed to FFM.
.
1142-182 Differences in Brain-Natriuretic Peptide and Left 
Ventricular Dimensions and Mass in Normotension, 
Prehypertension and Hypertension
Daniel A. Duprez, Gardar Sigurdsson, Paul Dasari, Natalia Florea, Lynn Hoke, Jay N. 
Cohn, University of Minnesota, Minneapolis, MN
Background: BNP and increase in left ventricular mass (LVM) are associated with
increased cardiovascular risk. The JNC VII guidelines for hypertension considernormo-
tension, prehypertension and hypertension. Surrogate end-markers for cardiovascular
damage in prehypertension are not known.
Objective: To study the significance of BNP and LVM as well as left ventricular enddias-
tolic diameter (LVIDD) in prehypertension versus normotension and hypertension.
Methods:
A total number of 159 subjects with normotension (BP < 120/80 mm Hg); 243 subjects
with prehypertension (BP 120-139/80-89 mm Hg) and 143 subjects with hypertension
(BP > 140/90 mm Hg) underwent an echocardiographic exam and a blood sampling for
BNP.
Results: Data are expressed as mean ± s.e.m. in Table 1. Statistical significance between
prehypertension and normotension and hypertension between prehypertension and nor-
motension has been calculated.
*P < 0.05; ** P < 0.01
Conclusions:
Prehypertension is characterized by a significantly higher LVIDD and LVM in comparison
with normotension and a lower LVIDD and LVM in comparison with hypertension. BNP is
not elevated in prehypertension, but is in hypertensive subjects. Thus prehypertension is
characterized by structural changes in the left ventricle not detectable by increases in
BNP.
2-way ANCOVA adjusting for age, sex and race
Normotensive Hypertensive
PFD (n=71) CFD (n=87) PFD (n=189) CFD (n=205)
BMI (kg/m2) 27 28 27 28*
Fat-free mass (kg) 49 52 48 51*
Adipose mass (kg) 26 32 26 31*
A/FFMr 0.59 0.67 0.60 0.68*
Cardiac output (l/min) 4.73 4.98 4.75 5.12*
Peripheral resistance 1638 1630 1779 1694#
Mean BP (mmHg) 94 98 103 104#
*effect of fat distribution; #effect of hypertension: 0.04<p<0.0001
NAA Women
(n=44)
NAA Men
(n=35)
AA Women
(n=22)
AA Men
(n=6)
Age (yrs) 48±9 48±13 53±14 52±13
LV Ejection
Fraction (%)
66±5 66±6 67±6 65±4
Systolic BP
(mmHg)
121±18 125±18 128±18 131±13
History of
Hypertension (%)
32 49 59 33
LVM/Ht2.7
(g/m2.7)
39±10 45±11 45±11 33±10
Frequency
C Allele
.18 .26 .52 .50
LVM by Gender (mean±SD)
Index None Ht Ht^2.7 BSA Wt Kvist Kuch
Men 156±29 88±16 33±6.5 76±14 1.8±0.36 2.42±0.43 2.55±0.46
Women 110±20 62±14 30±6.4 63±10 1.6±0.29 2.68±0.51 2.51±0.44
p-value <0.001 <0.001 <0.001 <0.001 <0.005 <0.005 0.45, *NS
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1142-183 Association of Prehypertension by Joint National 
Committee 7 Criteria With Left Ventricular Structure and 
Function: The Strong Heart Study
Marilyn B. Lawrence Wright, Richard B. Devereux, Mary J. Roman, Marcello Chinali, Lyle 
G. Best, James Galloway, Richard R. Fabsitz, Elisa T. Lee, Ying Zhang, Barbara V. 
Howard, Weill Medical College of Cornell University, New York, NY
Background: Hypertension (HTN) and left ventricular (LV) structure and function predict
cardiovascular events. The JNC 7 prehypertension (preHTN) category lowers the blood
pressure (BP) level at which cardiovascular risk for the general population is considered
significant. Methods: Using JNC 7 criteria to define BP groups, we compared clinical
features and LV structure and function in 776 normal BP (nlBP), 859 preHTN, 1,074
stage 1 HTN and 379 stage 2 HTN Strong Heart Study participants. Results: Partici-
pants were mostly female (63%), mean age 60 ± 8 years. Compared to the nlBP group,
preHTN and HTN participants were older, more obese, more likely to have diabetes and
less likely to smoke (all p < 0.01), with no difference in gender distribution, mean LDL or
HDL cholesterol. Plasma creatinine was higher with HTN and urine albumin/creatinine
ratio higher with preHTN and HTN (both p < 0.05). After adjusting for differences among
groups in age, diabetes, body mass index, smoking, study center and plasma creatinine,
LV mass and geometry were significantly different with preHTN and HTN compared to
nlBP. Compared to nlBP participants, LV systolic and diastolic function was significantly
different in HTN but not preHTN participants. (Table 1) Conclusion: PreHTN is associ-
ated with significant abnormalities of LV geometry and an increased prevalence of LV
hypertrophy. It is not associated with significant LV systolic or diastolic dysfunction. Fur-
ther research on clinical cardiovascular risk in preHTN is needed. 
1142-184 Contribution of Apolipoprotein A5 Gene Variants to Left 
Ventricle Hypertrophy in Hypertensive African-
American Men
Deborah Lyn, Rigobert Lapu-Bula, Cheryl Pack, Jason Nguyen, Jan Morgan, Elizabeth 
Ofili, Morehouse School of Medicine, Atlanta, GA
Background: Left ventricle mass (LVM) has been associated with metabolic measures
such as triglyceride levles in hypertensives (HTN). Variations in triglyceride levels have
been linked with polymorphisms in the apolipoprotein A5 (ApoA5) gene. It has not been
ascertained whether changes in cardiac structure are linked to APOA5 gene variants
related to hypertensive LV hypertrophy (LVH). Methods: The —1131T>C and 56C>G
(S19W) variants of the ApoA5 gene were determined in 92 normotensive and 123 HTN
African Americans without hyperlipedemia, diabetes or prior cardiac event. Echocardio-
grahic LVM was assessed to define LVH (>134/110 g/m2 men/women). Results: HTN
men bearing the —1131C and 56C alleles (C:C haplotype) had a significantly higher LVM
index compared to those with (T:C) haplotype. This association existed after multivariant
analysis when adjusted for body mass index. No significant differences in LVM were seen
in HTN women or normotensives related to these variants. Consistent with other studies,
the frequency of the 56G variant was linked to higher fasting triglyceride (p=0.05) and
lower HDL cholesterol (p=0.03) levels only in HTNs. Conclusion: These data suggest an
increased susceptibility to LVH in HTN men who carry the —1131C variant in the pro-
moter region. This study raises the possibility that apoA5 levels may play a role in lipid
transport in the development of cardiac hypertrophy.
LVM Index by Haplotypes in HTN 
Mean± SD g/m2 indexed to body surface area (n). Men p<0.01 Women p=0.84, T:C vs
C:C
1142-185 Cardiac Structural and Functional Responses to Salt 
Loading in Spontaneously Hypertensive Rats
Jwari Ahn, Jasmina Varagic, Dinko Susic, Michel Slama, Edward D. Frohlich, Ochsner 
Clinic Foundation, New Orleans, LA
Background: Increased dietary salt intake induces cardiac fibrosis in the spontaneously
hypertensive rat (SHR), yet little information details its effects on LV function. In addition,
young rats seem to be more susceptible to salt excess than older.
Methods: SHR at 8 or 20 weeks of age were given 8% salt diet; age-matched controls
received standard rat chow. Echocardiographic indices, arterial pressure and LV hydrox-
yproline concentration were measured at 16 and 52 weeks in the young and aged adult
SHR groups, respectively.
Results: In most SHR, given salt excess increased arterial pressure, LV mass and
hydroxyproline concentration associated with impaired LV relaxation manifested by pro-
longed isovolumic relaxation time, decreased early (E) and atrial filling (A) velocity ratio
(E/A) and slower propagation velocity of early filling (Vp). LV systolic function remained
normal. One-fourth of the young adult salt-loaded SHR developed cardiac failure associ-
ated with systolic and diastolic dysfunction with greater LV mass and fibrosis. These rats
had lower arterial pressure, decreased fractional shortening and restrictive pattern of
mitral flow. Shorter deceleration time of E wave and increased E/Vp ratio, an index of LV
filling pressure, indicated increased LV stiffness.
Conclusions: Increased sodium sensitivity in SHR not only is manifested by further eleva-
tion of blood pressure, but significant cardiac dysfunction, most likely related to ventricu-
lar fibrosis, also occurs, especially in the young.
1142-186 Elevated Levels of Circulating Tissue Inhibitor of 
Metalloproteinase-1 Correlate With Impaired Diastolic 
Relaxation in Hypertension: Implications for Diastolic 
Heart Failure
Muzahir H. Tayebjee, Sunil K. Nadar, Robert J. Macfadyen, Gregory YH Lip, City 
Hospital, Birmingham, United Kingdom
Background
Hypertension(HT), hypertensive heart disease and left ventricular (LV) hypertrophy are
integral to symptomatic diastolic heart failure. Tissue inhibitor of metalloproteinase 1
(TIMP-1) is linked to extracellular matrix fibrosis and is elevated in HBP. We explored the
link between circulating TIMP-1, matrix metalloproteinase 9 (MMP-9) and resting
echocardiographic LV filling.
Methods: Circulating MMP-9 and TIMP-1 levels were measured in citrated plasma by
ELISA in 52 patients with HT (38 male, age 57 + 11yrs) and 24 controls (15 male, mean
age 53+ 12years). Demography and standard resting echocardiographic indices of dias-
Table 1
Normotension Prehypertension Hypertension
SBP(mmHg) 109.0 ± 0.8 127.7± 0.4 150.2±0.9**
DBP (mmHg) 73.2±0.7 84.0±2.9* 89.6±0.8**
LVEDD (mm) 46.8±0.6 48.5±0.5* 49.8± 0.4*
LVM (g) 134.1±4.0 156.2±3.2* 178.9±5.9**
BNP (pg/ml) 22.0±2.2 21.8±2.3 30.7±3.2*
Table 1. LV Structure and Function in Study Participants grouped by BP Category
Variable NlBP
(N = 776)
PreHTN
(N = 859)
Stage 1 HTN
(N = 1074)
Stage 2 HTN
(N = 379)
LV end-diastolic diameter 
(cm)
4.89 ± 0.43 4.95 ± 
0.479 
5.03 ± 0.547 
β
5.12 ± 0.582 
β
Relative wall thickness 0.34 ± 
0.044
0.35 ± 
0.045*
0.35 ± 
0.049*
0.36 ± 
0.061_
LV Mass/height2.7 (g/m2.7) 37.5 ± 7.96 40.6 ± 8.84β 44.0 ± 11.06 
β
48.3 ± 13.32 
β
Eccentric LV Hypertrophy 
(%)
10.6 18.9 29.1 β 42.3 β
Concentric LV Hypertrophy 
(%)
1.0 2.1 3.2 6.1*
Ejection fraction (%) 64 ± 7.1 64 ± 7.7 62 ± 9.9 _ 61 ± 11.4 β
E/A ratio 0.92 ± 
0.291
0.86 ± 
0.249
0.82 ± 
0.348*
0.80 ± 0.369
Statistical significance versus nlBP: * = p < 0.05,  α = p < 0.01,  β = p < 0.001
T:C C:C T:G C:G
Male 112± 31 (39) 141± 44 (14) (0) (0)
Female 99± 27 (41) 101± 28 (17) 104± 30 (7) 72 (1)
Arterial Pressure and Echocardiographic Indices
ADULT
CONTROL
ADULT 
SALT
without CF
ADULT SALT
with CF
AGED
CONTROL
AGED
SALT
Arterial 
Pressure
(mmHg)
206 ± 9 243 ± 8* 164 ± 18*† 207 ± 6 242 ± 78*
LV Mass (g) 0.86 ± 0.04 1.12 ± 0.04* 1.39 ± 0.07*† 1.31± 0.03 1.53 ± 
0.06*
Left End 
Diastolic
Diameter (cm)
0.73 ± 0.02 0.75 ± 0.01 0.85 ± 0.02*† 0.84 ± 0.01 0.87± 0.02
Fractional
Shortening (%)
41 ± 1 44 ± 1 35 ± 1*† 41.2 ± 1 44.3± 1
E/A 2.56 ± 0.12 1.50 ± 0.12* 2.54 ± 0.20† 2.58 ± 0.21 2.18± 0.15
Deceleration 
Time
of E Wave (sec)
0.045 ± 
0.001
0.040 ± 
0.002*
0.036 ± 
0.002*
0.046 ± 
0.002
0.042 ± 
0.002
Vp (cm/s) 28.5 ± 0.76 25.1 ± 0.56* 24.9 ± 1.22* 24.7 ± 0.65 24.6 ± 0.63
E/Vp 0.028 ± 
0.001
0.031 ± 
0.001
0.039 ± 
0.002*†
0.032 ± 
0.001
0.034 ± 
0.001
LV 
Hydroxyproline
(mg/g)
4.57 ± 0.17 5.75 ± 0.12* 6.84 ± 0.57*† 4.85 ± 0.24 6.02 ± 
0.49*
*p<0.05 vs Respective Control, †p<0.05 vs Adult Salt without CF
